NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

What should scare independent retail shareholders is that no one is daring to attack your post or even to stoop to attacking you personally for simply saying such things.

That suggests that the voices which (coincidentally or not) reflect Bethesda’s thinking know it is highly likely that this will come to pass or (if they are somehow connected) know it is planned and that attacks on you would not age well at all.

Remember that NWBO publicly admitted that they planned to spring an R/S on us to avoid NASDAQ delisting and they only stopped because conditions did not allow the R/S to make a difference. They likewise sprang the news of expanding and delaying the Phase 3 trial on us years ago with next to no warning, so just because they are keeping their mouths shut about bad things ahead (from a retail standpoint) does not that they will not repeat history.

The same (unfortunately) increasing potential for an R/S (due to the rising share count alone) that used to be attacked as FUD will suddenly be trumpeted as sound business strategy and an inevitable necessity that ‘everyone knew’ was to be expected.

How NWBO handles MHRA approval will be crucial in determining if you are right and I hold out hope that NWBO will finally listen to shareholders like me and do right by us in fully and vigorously exploiting the catalyst.

I am afraid however that given their access to earning shares from other means than buying them with cash money as we do, I am not sure that their incentives and our incentives are fully aligned when it comes to avoiding an R/S.

Again we will know whether you are right or wrong not even by waiting for the ASM but simply from how MHRA approval is handled and how effectively management fights to get us to the SP we need.